Hexagon Bio
Menlo Park
About Hexagon Bio
Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics. Our proprietary platform combines data science and synthetic biology to discover and engineer drugs from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $193.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2022)
- Website: hexagonbio.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/hexagon-bio-102333 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.